Yu, Margaret K.
Vart, Priya
Jongs, Niels
Correa-Rotter, Ricardo
Rossing, Peter
McMurray, John J.V.
Hou, Fan-Fan
Douthat, Walter
Khullar, Dinesh
Langkilde, Anna Maria
Wheeler, David C.
Heerspink, Hiddo J. L.
Chertow, Glenn M. http://orcid.org/0000-0002-7599-0534
Funding for this research was provided by:
AstraZeneca
Article History
Received: 9 May 2023
Accepted: 24 August 2023
First Online: 14 December 2023
Declarations:
:
: MKY reports current research funding from the NIH and George Clinical, prior research support from AstraZeneca as a site PI for DAPA-CKD, and has received an honorarium from Bayer.PV reports no conflicts of interests.NJ reports travel grants from AstraZeneca.RC-R has received support from AstraZeneca for this manuscript as being a member for the DAPA-CKD steering committee. He has received grants from AstraZeneca, GlaxoSmithKline, and Novo Nordisk; and honoraria as a speaker fees from From AstraZeneca, Bayer, Boehringer Ingelheim, Amgen, and Janssen. He has received support for a leadership/fiduciary role from the Latin American Society of Nephrology as a member of the Diabetes Committee.PR has received honoraria to Steno Diabetes Center Copenhagen for steering group participation from AstraZeneca for this manuscript. He has received grants from AstraZeneca, Novo Nordisk, and Bayer; and consulting fees from Astellas, Astra Zeneca, Boehringer Ingelheim, Bayer, Gilead, Novo Nordisk, Merck, and Sanofi. He has also received honoraria/payment from Eli-Lilly as speaker fees.JJVM has received payments to his employer, Glasgow University, as support on the current manuscript from AstraZeneca. He has received payment/honoraria for lecture fees from Abbott, Alkem Metabolics, Eris Lifesciences, Astra Zeneca, Blue Ocean Scientific Solutions Ltd., Boehringer Ingelheim, Canadian Medical and Surgical Knowledge, Emcure Pharmaceuticals Ltd., Eris Lifesciences, European Academy of CME, Hikma Pharmaceuticals, Imagica Health, Intas Pharmaceuticals, J.B. Chemicals & Pharmaceuticals Ltd., Lupin Pharmaceuticals, Medscape/Heart.Org., ProAdWise Communications, Radcliffe Cardiology, Sun Pharmaceuticals, The Corpus, Translation Research Group, Translational Medicine Academy. His institution has also received fees for his work on clinical trials, consulting and other activities from AstraZeneca, Amgen, Bayer, cardurion, Cytokinetics, Glaxo Smith Kline, KBP Biosciences and Novartis. He has received fees from George Clinical PTY Ltd for participation on a data safety monitoring board or advisory board.F-FH has received honoraria from AstraZeneca for serving as an executive committee member and a national leader in DAPA-CKD study.WD has received honoraria and/or consultancy fees from Amgen, AstraZeneca, Ultragenix.DK received support from AstraZeneca for being the national research lead from India for the DAPA-CKD study.AML is an employee and stockholder of AstraZeneca.DCW has received support from AstraZeneca for the current manuscript and consultancy fees from Amgen, Boehringer Ingelheim, Eledon, GlaxoSmithKline, Gillead, George Clinical, Galderma Janssen, Mundipharma, Merck Sharp and Dohme, ProKidney, Tricida, Vifor, and Zydus. He has received honoraria from Astellas, AstraZeneca, Boehringer Ingelheim, Intas, and Vifor; and travel grants from AstraZeneca, Astellas. He has received a grant for the NIHR HTA programme and has played a leadership/fiduciary role as the NIHR National specialty Lead for Renal Disorders (UK).HJLH has received a grant/contract from AstraZeneca, Boehringer Ingelheim, Janssen, Novo Nordisk and has received consulting fees from AstraZeneca, Abbvie, Boehringer Ingelheim, CSL Behring, Bayer, Chinook, Dimerix, EliLilly, Gilead, Goldfinch, Merck, Novartis, NovoNordisk, Janssen, Travere Pharmaceuticals. He has received honoraria from AstraZeneca and Novo Nordisk. He has received a travel grant from Eli-Lilly.GMC has served on the Board of Directors of Satellite Healthcare, a non-profit dialysis provider. He has served as Chair or Co-Chair of Trial Steering Committees with Akebia, AstraZeneca, CSL Behring, Sanifit, and Vertex. He has served as an Advisor to Applaud, Ardelyx, CloudCath, Durect, Eliaz Therapeutics, Miromatrix, Outset, Physiowave, Renibus, and Unicycive. He has served on Data Safety Monitoring Boards with Bayer, Mineralys, and ReCor.